The markets tumbled to a sharply lower open with the Dow plunging 131 points to 19,839 as corporate earnings disappoint. Nasdaq dropped 31 points to 5,582.
On the upside
DryShips (Nasdaq: DRYS) completed its $200 million common stock offering.
Aeterna Zentaris (Nasdaq: AEZS) completed the clinical phase of its Phase 3 clinical study of Zoptrex.
Rising gold prices lifted shares of AngloGold Ashanti (NYSE: AU).
On the downside
Fourth quarter earnings and revenue for Under Armour (NYSE: UAA) fell short of expectations and the athletic apparel maker forecast 2017 revenue below estimates.
SeaDrill (NYSE: SDRL) extended its talks to restructure its debt and needs to raise $1 billion in new capital.
A district court rejected all four of Teva Pharmaceutical's (NYSE: TEVA) patent infringement claims.
In the broad market, declining issues outpaced advancers by a margin of nearly 9 to 7 on the NYSE and by 5 to 3 on Nasdaq. The broader S&P 500 index fell 9 points to 2,270. Bitcoin soared $30 to $946.
